WSQMS Homepage


May 13, 2016

Widler & Schiemann open Office in China!
Widler & Schiemann opened their office in Shanghai to support Chinese & Asia-Pacific Pharma and Biotech companies in collaboration with 3Audit

Widler & Schiemann together with 3 Audit, a Bejing-based Audit Services Company (,, opened their subsidiary in Shanghai in April. The subsidiary will be managed by Dr. Peter Schiemann, who moved to Shanghai to build our Asia-Pacific practice. Many guests from pharmaceutical companies and hospitals attended the opening ceremony. We are very proud to be able to offer to our clients now a support directly out of China.

Read more online

EMA Pharmacovigilance Updates
Recent EMA updates on latest Pharmacovigilance guidance

EMA 29/04/2016 Newsletter: What's new in pharmacovigilance - QPPV Update - Issue 1

29/04/2016 Regulatory and procedural guideline: Reflection paper on collecting and reporting information on off-label use in pharmacovigilance, draft: consultation open

29/04/2016 Pharmacovigilance: Regulatory and procedural guidance (updated)

28/04/2016 Quality of medicines questions and answers: Part 2 (updated)

How objective is the RACT?
Comments on the RACT by TransCelerate published in Applied Clinical Trials co-authored by Widler & Schiemann

The biopharmaceutical industry is starting to adopt TransCelerate’s Risk Assessment Categorization Tool (RACT) in order to identify risks and plan a comprehensive clinical trial risk mitigation strategy. But how good is it really? Does it address all requirements by regulators?

In this article, we will leverage industry-wide RACT data (provided by Cyntegrity) to see what are the most common study-related risks that people choose.

Read more online

Widler & Schiemann accredited with the Swiss Center Shanghai
Widler & Schiemann AG is also accredited with the SCS, a non-profit organization for fostering business in China

Widler & Schiemann are now also accredited with the SCS (Swiss Center in Shanghai), a non-profit organization serving the Swiss economy by providing adapted services for SME’s intending to and/or entering the Chinese and/or the Asian markets. In the past 10 years, SCS has created a pool of services through companies accessing these markets with a full range of practical, direct and accredited services offered at favorable conditions and integrated tailor-made packages to provide truly efficient solutions.

Read the pdf


You receive this newsletter, because you have subscribed to it.
If you no longer want to receive this newsletter, you can easily leave the list at this Website.You can't view the images in this e-mail? Click here to open it in your browser.

Widler & Schiemann AG - Weinberghöhe 10 B - CH 6300 Zug, Switzerland - VAT number: CHE-472.215.777 MWST - Public Limited Company according to Swiss Common Law - Managing Partner: Dr. Beat Widler, Dr. Peter Schiemann - +41 41 558 9193 - -